Progress in dodecafluoropentane emulsion as a neuroprotective agent in a rabbit stroke model

Molecular Neurobiology

Volumn 48, Issue 2, 2013, Pages 363-367

  Woods, S D ^a   Skinner, R D ^a,b   Ricca, A M ^a   Brown, A T ^a   Lowery, J D ^a   Borrelli, M J ^a   Lay, J O ^c   Culp, W C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Dodecafluoropentane emulsion; Neuroprotective agent; Rabbit; Stroke model

Indexed keywords

NEUROPROTECTIVE AGENT; PERFLUOROPENTANE;

ARTIFICIAL EMBOLISM; BLOOD SAMPLING; BRAIN ANGIOGRAPHY; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; DOSE RESPONSE; DRUG HALF LIFE; EMULSION; MASS FRAGMENTOGRAPHY; MIDDLE CEREBRAL ARTERY OCCLUSION; PARTICLE SIZE; PLASMA CLEARANCE; RABBIT; TREATMENT DURATION;

ANIMALS; BRAIN; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; EMULSIONS; FLUOROCARBONS; NEUROPROTECTIVE AGENTS; RABBITS; STROKE; TIME FACTORS;

EID: 84885295033     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8495-6     Document Type: Conference Paper

References (18)

1. Kochanek K, Xu J, Murphy SL, Minino AM, Kung H-C (2011) Deaths: Final data for 2009. Natl Vital Stat Rep 60(3):1-117
2. Roger VL et al (2012) AHA statistical update: heart diseases and stroke statistics-2012 Update. Circulation 125:e2-e220, ePub Dec 15, 2011
3. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO, Trialists SWIFT (2012) Solitaire flow restoration device versus the Merci Retriever in patients with acute ischemic stroke (SWIFT): a randomized, parallel-group, non-inferiority trial (2012). Lancet 380(9849):1241-1249
4. Donnan GA (2009) The 2007 Feinberg lecture: a new road map for neuroprotection. Stroke 39:242-248
5. Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hardemart HG, Rodichok L, SAINT I and II Investigators (2008) NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke 39:1751-1758
6. Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z, Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators (2012) Cerebrolysin in patients with acute ischemic stroke in Asia: result of a double-blind, placebo-controlled randomized trial. Stroke 43(3):630-636
7. Johnson JLC, Dolezal MC, Kerschen A, Matsunaga TO, Unger EC (2009) In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange. Artif Cell Blood 37:156-162
8. Culp WC, Woods SD, Skinner RD, Brown AT, Lowery JD, Johnson JLH, Unger EC, Hennings LJ, Borrelli MJ, Roberson PK (2012) Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model. J Vasc Interv Radiol 23:116-121
9. Correas JM, Quay SC (1996) EchoGen emulsion: a new ultrasound contrast agent based on phase shift colloids. Clin Radiol 51(S1):11-14
10. Culp WC, Woods SD, Brown AT, Lowery JD, Hennings LJ, Skinner RD, Borrelli MJ, Roberson PK. Three variations in rabbit angiographic stroke models. J Neurosci Meth, Epub ahead of print Nov 8 2012, doi: 10.1016/j/jneurometh.2012. 10.107
11. Reiss JG (2005) Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol 33:47-63
12. Remy B, Deby-Dupont G, Lamy M (1999) Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions. Br Med Bull 55:277-298
13. The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit, 27 July 1998, CPMP/1342/98
14. Lundgren CEG, Bergoe GW, Tyssebotn IM (2006) Intravascular fluorocarbon-stabilized microbubbles protect against fatal anemia in rats. Artif Cell Blood Sub 34:473-486
15. Tyssebotn IM, Lundgren CE, Olszowka AJ, Bergoe GW (2010) Hypoxia due to shunts in pig lung treated with O2 and fluorocarbon-derived intravascular microbubbles. Artif Cells Substit Immobil Biotechnol 38(2):79-89
16. Grayburn PA, Erickson JM, Excobar J, Womack L, Velasco CE (1995) Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol 26(5):1340-1347
17. Khor SP (2012) Amendment to the pharmacokinetic analysis of clinical data from study SON-3600-1004a: NuvOx Formal Study Report
18. Correas JM, Meuter AR, Singlas E, Kessler DR, Worah D, Quay SC (2001) Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound Med Biol 27:565-570